SelectScienceIndustry News: Dual-Targeted CAR T-cell Line Shows Promising Results in Preclinical Cancer Immunotherapy StudySelectScience“We aimed to overcome these challenges by demonstrating proof-of-concept for an off-the-shelf, dual-targeted CAR T-c… Continue reading
SelectScienceIndustry News: Dual-Targeted CAR T-cell Line Shows Promising Results in Preclinical Cancer Immunotherapy StudySelectScience“We aimed to overcome these challenges by demonstrating proof-of-concept for an off-the-shelf, dual-targeted CAR T-c… Continue reading
EurekAlertResearchers Identify Essential Genes for Pluripotent Stem Cells Through CRISPR-Cas9 ScreeningGenomeWebNEW YORK (GenomeWeb) – Researchers at the Hebrew University in Jerusalem, Israel have built a reference library of essential and growth-rest… Continue reading
Asbestos.comLatest Mesothelioma Immunotherapy Combination Looks PromisingAsbestos.comScientists at the Vaccine and Immunotherapy Center (VIC) at Massachusetts General Hospital have uncovered a novel, two-agent immunotherapy combination that worked surp… Continue reading
|
ViaCyte Substantially Expands Patent Portfolio in Stem Cell-Derived Cell Replacement Therapies for Type 1 Diabetes …
PR Newswire (press release) “ViaCyte’s intellectual property covers directed differentiation to various cell types from numerous pluripotent stem cell sources, including embryonic and induced pluripotent stem cells, by multiple methods, as well as delivery and encapsulation … |